Seeking Alpha

RVNC
  Revance Therapeutics, Inc. - NASDAQ

9/22/2014, 6:13 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
RVNC vs. ETF Alternatives
Company Description
Revance Therapeutics Inc is a clinical stage specialty biopharmaceutical company, engaged in the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.
Sector: Healthcare
Industry: Biotechnology
Country: United States